HRP20060448T3 - Novi spojevi s 14 i 15-članim prstenovima - Google Patents

Novi spojevi s 14 i 15-članim prstenovima

Info

Publication number
HRP20060448T3
HRP20060448T3 HR20060448T HRP20060448T HRP20060448T3 HR P20060448 T3 HRP20060448 T3 HR P20060448T3 HR 20060448 T HR20060448 T HR 20060448T HR P20060448 T HRP20060448 T HR P20060448T HR P20060448 T3 HRP20060448 T3 HR P20060448T3
Authority
HR
Croatia
Prior art keywords
member rings
hydrogen
optionally substituted
new joints
bicyclic heteroaryl
Prior art date
Application number
HR20060448T
Other languages
English (en)
Croatian (hr)
Inventor
Alihodzic Sulejman
Keith Forrest Andrew
Lewis Jarvest Richard
Lazarevski Gorjana
Pavlovic Drazen
Original Assignee
Glaxo Group Limited
Glaxosmithkline Istrazivacki Centar Zagreb D.O.O.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited, Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. filed Critical Glaxo Group Limited
Publication of HRP20060448T3 publication Critical patent/HRP20060448T3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR20060448T 2003-05-13 2004-05-11 Novi spojevi s 14 i 15-članim prstenovima HRP20060448T3 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0310986.5A GB0310986D0 (en) 2003-05-13 2003-05-13 Novel compounds
PCT/EP2004/005082 WO2004101586A1 (en) 2003-05-13 2004-05-11 Novel 14 and 15 membered-ring compounds

Publications (1)

Publication Number Publication Date
HRP20060448T3 true HRP20060448T3 (hr) 2007-03-31

Family

ID=9957984

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20060448T HRP20060448T3 (hr) 2003-05-13 2004-05-11 Novi spojevi s 14 i 15-članim prstenovima

Country Status (22)

Country Link
US (1) US7569550B2 (enExample)
EP (1) EP1628988B1 (enExample)
JP (1) JP2007502313A (enExample)
KR (1) KR20060026407A (enExample)
CN (1) CN1849328A (enExample)
AR (1) AR044309A1 (enExample)
AT (1) ATE341560T1 (enExample)
AU (1) AU2004238528A1 (enExample)
BR (1) BRPI0410246A (enExample)
CA (1) CA2525452A1 (enExample)
CL (1) CL2004001010A1 (enExample)
DE (1) DE602004002696T2 (enExample)
DK (1) DK1628988T3 (enExample)
ES (1) ES2273255T3 (enExample)
GB (1) GB0310986D0 (enExample)
HR (1) HRP20060448T3 (enExample)
MX (1) MXPA05012163A (enExample)
PL (1) PL1628988T3 (enExample)
PT (1) PT1628988E (enExample)
RU (1) RU2005134908A (enExample)
WO (1) WO2004101586A1 (enExample)
ZA (1) ZA200509079B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
EP1851236B1 (en) * 2005-01-13 2010-08-04 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. Macrolides with anti-inflammatory activity
WO2006120541A1 (en) * 2005-05-10 2006-11-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ether linked macrolides useful for the treatment of microbial infections
PE20070802A1 (es) * 2005-11-09 2007-10-19 Glaxo Group Ltd Derivados de eritromicina 4''-sustituidos como agentes antimicrobianos
EP1945652A1 (en) * 2005-11-09 2008-07-23 Glaxo Group Limited Macrolones
EP2384333B1 (en) 2009-01-30 2013-04-17 Glaxo Group Limited Anti-inflammatory macrolide
CN111574575B (zh) * 2020-04-29 2022-05-17 北京理工大学 一种含有大环内酯基的喹喏酮衍生物、制备方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE128714T1 (de) * 1989-03-28 1995-10-15 Abbott Lab Erythromycinderivate.
WO1996034007A1 (es) * 1995-04-27 1996-10-31 Laboratorios Aranda, S.A. De C.V. Derivados de quinolonilcarboxieritromicina y composiciones farmaceuticas que los contienen
CA2253451A1 (en) * 1996-05-07 1997-11-13 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides
WO2003014136A1 (en) * 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides

Also Published As

Publication number Publication date
US20070185117A1 (en) 2007-08-09
ATE341560T1 (de) 2006-10-15
AR044309A1 (es) 2005-09-07
CA2525452A1 (en) 2004-11-25
GB0310986D0 (en) 2003-06-18
EP1628988A1 (en) 2006-03-01
MXPA05012163A (es) 2006-05-19
CL2004001010A1 (es) 2005-03-18
CN1849328A (zh) 2006-10-18
RU2005134908A (ru) 2006-06-27
DE602004002696T2 (de) 2007-08-16
PL1628988T3 (pl) 2007-03-30
ES2273255T3 (es) 2007-05-01
AU2004238528A1 (en) 2004-11-25
DK1628988T3 (da) 2007-02-05
ZA200509079B (en) 2007-02-28
DE602004002696D1 (de) 2006-11-16
WO2004101586A1 (en) 2004-11-25
EP1628988B1 (en) 2006-10-04
KR20060026407A (ko) 2006-03-23
BRPI0410246A (pt) 2006-05-16
JP2007502313A (ja) 2007-02-08
US7569550B2 (en) 2009-08-04
PT1628988E (pt) 2007-01-31

Similar Documents

Publication Publication Date Title
HRP20030003B1 (en) N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
ATE506354T1 (de) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
CO4960662A1 (es) Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
HRP20090162T1 (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
PE20030762A1 (es) Compuestos heterociclicos como antagonistas nk1
SE0000540D0 (sv) New compounds
BR0109991A (pt) Composição farmacêutica
EA200000155A2 (ru) 4-фенилпиридиновые производные
ES2008359A6 (es) Procedimiento para preparar nuevos derivados de catecol farmacologicamente activos.
CO6270328A2 (es) Derivados de pirrolo [2,3] pirimidina como inhibidores de proteinas quinasas b
ATE449099T1 (de) Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren
ECSP066967A (es) Derivados de tetrahidroquinolina y un procedimiento para preparar los mismos
ATE297910T1 (de) Retinoid x rezeptormodulatoren
MEP24608A (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
HRP20060448T3 (hr) Novi spojevi s 14 i 15-članim prstenovima
EA200300558A1 (ru) Агонисты альфа-рецепторов, активируемых пролифератором пероксисомы
YU68896A (sh) Jedinjenja hinolina i nihazolina od koristi u terapiji
AR041395A1 (es) Compuesto de piridina composicion farmaceutica que lo comprende y su uso para prepararla
DE69312091D1 (de) Piperazinderivate als 5-ht antagonisten
ATE377001T1 (de) Pleuromutilinderivate als antimikrobielle mittel
CL2020002253A1 (es) Derivados de 2,4 - diaminoquinazolina y usos médicos de los mismos.
DE69507293D1 (de) Benzamid-derivate als vasopressin-antagonisten
PE20020144A1 (es) Derivados de pleuromutilinas como agentes antibacterianos
AR058701A1 (es) Derivados de piracinil-s-espiro-oxacinoquinolin-pirimidin-triona como agentes antibacterianos
ATE12769T1 (de) Imidazolinderivate.